Crystalys Therapeutics Advances Phase 3 Trials of Dotinurad for the Treatment of Gout with Dosing of First Patients October 23, 2025
James Mackay is tending to ‘unfinished business’ with new gout biotech and $205M fundraise September 30, 2025
Crystalys lands $205M to bring gout drug first marketed in Japan to the US and Europe September 30, 2025
Crystalys Therapeutics Launches with $205M Series A Financing to Transform the Treatment of Gout September 30, 2025
